Immunovia AB Company Description

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden.

It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual.

Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Immunovia AB (publ)

Country	Sweden
Founded	2007
Industry	Medical - Diagnostics & Research
Sector	Healthcare
Employees	11
CEO	Jeff Borcherding

Contact Details

Address: Medicon Village Lund, 223 63 Sweden
Phone	46 4 62 75 60 00
Website	immunovia.com

Stock Details

Ticker Symbol	0G8X
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0006091997
SIC Code	2836

Key Executives

Name	Position
Jeff Borcherding	Chief Executive Officer of US, Immunovia, Inc.
Philipp Mathieu	Chief Executive Officer and Pres
Karin Almqvist Liwendahl	Chief Financial Officer
Linda Dexlin Mellby	Vice President of Research & Development